These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 18330544)

  • 1. Effects of tryptophan deficiency on prepulse inhibition of the acoustic startle in rats.
    Bortolato M; Frau R; Orrù M; Collu M; Mereu G; Carta M; Fadda F; Stancampiano R
    Psychopharmacology (Berl); 2008 Jun; 198(2):191-200. PubMed ID: 18330544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic tryptophan deprivation attenuates gating deficits induced by 5-HT(1A), but not 5-HT₂ receptor activation.
    Stancampiano R; Frau R; Bini V; Collu M; Carta M; Fadda F; Bortolato M
    Eur Neuropsychopharmacol; 2013 Oct; 23(10):1329-35. PubMed ID: 23141373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic NT69L potently prevents drug-induced disruption of prepulse inhibition without causing tolerance.
    Briody S; Boules M; Oliveros A; Fauq I; Richelson E
    Behav Brain Res; 2010 Feb; 207(1):118-24. PubMed ID: 19800922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prepulse inhibition of acoustic startle, a measure of sensorimotor gating: effects of antipsychotics and other agents in rats.
    Johansson C; Jackson DM; Zhang J; Svensson L
    Pharmacol Biochem Behav; 1995 Dec; 52(4):649-54. PubMed ID: 8587900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of antipsychotic and propsychotic drugs on prepulse inhibition and locomotor activity in Roman high- (RHA) and low-avoidance (RLA) rats.
    Oliveras I; Sánchez-González A; Sampedro-Viana D; Piludu MA; Río-Alamos C; Giorgi O; Corda MG; Aznar S; González-Maeso J; Gerbolés C; Blázquez G; Cañete T; Tobeña A; Fernández-Teruel A
    Psychopharmacology (Berl); 2017 Mar; 234(6):957-975. PubMed ID: 28154892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of nicotinic receptors in the lateral habenula in the attenuation of amphetamine-induced prepulse inhibition deficits of the acoustic startle response in rats.
    Larrauri JA; Burke DA; Hall BJ; Levin ED
    Psychopharmacology (Berl); 2015 Aug; 232(16):3009-17. PubMed ID: 25912180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PPI deficit induced by amphetamine is attenuated by the histamine H1 antagonist pyrilamine, but is exacerbated by the serotonin 5-HT2 antagonist ketanserin.
    Larrauri JA; Levin ED
    Psychopharmacology (Berl); 2010 Dec; 212(4):551-8. PubMed ID: 20811878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of haloperidol and clozapine on sensorimotor gating deficits induced by 5-hydroxytryptamine depletion in the brain.
    Kusljic S; Brosda J; van den Buuse M
    Br J Pharmacol; 2006 Apr; 147(7):800-7. PubMed ID: 16415909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of phencyclidine-induced prepulse inhibition deficits by clozapine in monkeys.
    Linn GS; Negi SS; Gerum SV; Javitt DC
    Psychopharmacology (Berl); 2003 Sep; 169(3-4):234-9. PubMed ID: 12845408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Failure of haloperidol to block the effects of phencyclidine and dizocilpine on prepulse inhibition of startle.
    Keith VA; Mansbach RS; Geyer MA
    Biol Psychiatry; 1991 Sep; 30(6):557-66. PubMed ID: 1834231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating the antipsychotic profile of the preferential PDE10A inhibitor, papaverine.
    Weber M; Breier M; Ko D; Thangaraj N; Marzan DE; Swerdlow NR
    Psychopharmacology (Berl); 2009 May; 203(4):723-35. PubMed ID: 19066855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurotensin-deficient mice have deficits in prepulse inhibition: restoration by clozapine but not haloperidol, olanzapine, or quetiapine.
    Kinkead B; Dobner PR; Egnatashvili V; Murray T; Deitemeyer N; Nemeroff CB
    J Pharmacol Exp Ther; 2005 Oct; 315(1):256-64. PubMed ID: 15987829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sleep deprivation disrupts prepulse inhibition of the startle reflex: reversal by antipsychotic drugs.
    Frau R; Orrù M; Puligheddu M; Gessa GL; Mereu G; Marrosu F; Bortolato M
    Int J Neuropsychopharmacol; 2008 Nov; 11(7):947-55. PubMed ID: 18477413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of haloperidol, clozapine, and quetiapine on sensorimotor gating in a genetic model of reduced NMDA receptor function.
    Duncan GE; Moy SS; Lieberman JA; Koller BH
    Psychopharmacology (Berl); 2006 Jan; 184(2):190-200. PubMed ID: 16362405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of dopamine in prepulse inhibition of acoustic startle.
    Zhang J; Forkstam C; Engel JA; Svensson L
    Psychopharmacology (Berl); 2000 Apr; 149(2):181-8. PubMed ID: 10805614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperactivity and disruption of prepulse inhibition induced by N-methyl-D-aspartate stimulation of the ventral hippocampus and the effects of pretreatment with haloperidol and clozapine.
    Bast T; Zhang WN; Heidbreder C; Feldon J
    Neuroscience; 2001; 103(2):325-35. PubMed ID: 11246148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced startle gating after D1 blockade: effects of concurrent D2 blockade.
    Swerdlow NR; Shoemaker JM; Bongiovanni MJ; Neary AC; Tochen LS; Saint Marie RL
    Pharmacol Biochem Behav; 2005 Oct; 82(2):293-9. PubMed ID: 16188305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (+/-) Ketamine-induced prepulse inhibition deficits of an acoustic startle response in rats are not reversed by antipsychotics.
    Cilia J; Hatcher P; Reavill C; Jones DN
    J Psychopharmacol; 2007 May; 21(3):302-11. PubMed ID: 17591657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rat strain differences in the ability to disrupt sensorimotor gating are limited to the dopaminergic system, specific to prepulse inhibition, and unrelated to changes in startle amplitude or nucleus accumbens dopamine receptor sensitivity.
    Kinney GG; Wilkinson LO; Saywell KL; Tricklebank MD
    J Neurosci; 1999 Jul; 19(13):5644-53. PubMed ID: 10377370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haloperidol differentially modulates prepulse inhibition and p50 suppression in healthy humans stratified for low and high gating levels.
    Csomor PA; Stadler RR; Feldon J; Yee BK; Geyer MA; Vollenweider FX
    Neuropsychopharmacology; 2008 Feb; 33(3):497-512. PubMed ID: 17460616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.